Department of Cell Research and Immunology
Vered Padler-Karavani has not added Biography.
If you are Vered Padler-Karavani and would like to personalize this page please email our Author Liaison for assistance.
Characterization of yeast V-ATPase mutants lacking Vph1p or Stv1p and the effect on endocytosis.
The Journal of experimental biology May, 2002 | Pubmed ID: 11948198
Biochemical support for the V-ATPase rotary mechanism: antibody against HA-tagged Vma7p or Vma16p but not Vma10p inhibits activity.
The Journal of experimental biology Sep, 2003 | Pubmed ID: 12909704
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.
Glycobiology Oct, 2008 | Pubmed ID: 18669916
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2008 | Pubmed ID: 19017806
Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.
PloS one , 2009 | Pubmed ID: 19156207
Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.
Blood Dec, 2009 | Pubmed ID: 19828701
Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.
The Journal of experimental medicine Aug, 2010 | Pubmed ID: 20624889
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.
Nature biotechnology Aug, 2010 | Pubmed ID: 20657583
Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.
Xenotransplantation Jan-Feb, 2011 | Pubmed ID: 21342282
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Cancer research May, 2011 | Pubmed ID: 21505105
LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion.
Analytical chemistry Mar, 2012 | Pubmed ID: 22390546
Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays.
The Journal of biological chemistry Jun, 2012 | Pubmed ID: 22549775
Specific inactivation of two immunomodulatory SIGLEC genes during human evolution.
Proceedings of the National Academy of Sciences of the United States of America Jun, 2012 | Pubmed ID: 22665810
Quantum dot nanometal surface energy transfer based biosensing of sialic acid compositions and linkages in biological samples.
Analytical chemistry Apr, 2013 | Pubmed ID: 23489180
A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease.
PloS one , 2013 | Pubmed ID: 23520510
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2013 | Pubmed ID: 23945141
Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
Cancer letters Sep, 2014 | Pubmed ID: 24141190
Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Mar, 2014 | Pubmed ID: 24308974
Glycans in immune recognition and response.
Carbohydrate research May, 2014 | Pubmed ID: 24680512
Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins.
Cell reports Jun, 2015 | Pubmed ID: 26095364
Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
Xenotransplantation Sep, 2016 | Pubmed ID: 27610947
Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray.
Organic & biomolecular chemistry Nov, 2016 | Pubmed ID: 27714250
Glycan Microarray Reveal the Sweet Side of Cancer Vaccines.
Cell chemical biology Dec, 2016 | Pubmed ID: 28009977
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved